TC Biopharm shareholders approve 25% stock dividend

TC BioPharm (TCBP) announced that shareholders have formally approved the recently announced 25% stock dividend. TC BioPharm declared that last week’s proposed special stock dividend was formally approved at today’s General Meeting of the Company. The special dividend of 0.25 American Depositary Shares for every 1 ADS held by shareholders on the record date of January 2, 2025 are expected to be delivered to shareholders on or about January 6th. Per Nasdaq requirements, trading in the Company’s ADSs will temporarily stop at 5:00 pm on January 2, 2025, and recommence on or around January 8, 2025, to allow the Depositary to process the stock dividend. Nasdaq will adjust the opening price on January 8 to reflect the dilution impact of the stock dividend.